Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter Study

Clinical trial NCT05328336 · UNKNOWN

Trial details

NCT number: NCT05328336
Sponsor: Tianjin Medical University Second Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Muscle Invasive Bladder Cancer Urothelial Carcinoma

Start date: 2021-11-11
Primary completion: 2025-07-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.